307321-52-4Relevant academic research and scientific papers
Development of a sphingosine kinase 1 specific small-molecule inhibitor
Hengst, Jeremy A.,Wang, Xujun,Sk, Ugir H.,Sharma, Arun K.,Amin, Shantu,Yun, Jong K.
, p. 7498 - 7502 (2011/02/22)
The sphingolipid metabolic pathway represents a potential source of new therapeutic targets for numerous hyperproliferative/inflammatory diseases. Targets such as the sphingosine kinases (SphKs) have been extensively studied and numerous strategies have b
